skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ

Abstract

Myoepithelial cells play key roles in normal mammary gland development and in limiting pre-invasive to invasive breast tumor progression, yet their differentiation and perturbation in ductal carcinoma in situ (DCIS) are poorly understood. Here, we investigated myoepithelial cells in normal breast tissues of BRCA1 and BRCA2 germline mutation carriers and in non-carrier controls, and in sporadic DCIS. We found that in the normal breast of non-carriers, myoepithelial cells frequently co-express the p63 and TCF7 transcription factors and that p63 and TCF7 show overlapping chromatin peaks associated with differentiated myoepithelium-specific genes. In contrast, in normal breast tissues of BRCA1 mutation carriers the frequency of p63+TCF7+ myoepithelial cells is significantly decreased and p63 and TCF7 chromatin peaks do not overlap. These myoepithelial perturbations in normal breast tissues of BRCA1 germline mutation carriers may play a role in their higher risk of breast cancer. The fraction of p63+TCF7+ myoepithelial cells is also significantly decreased in DCIS, which may be associated with invasive progression.

Authors:
 [1];  [2];  [3];  [4];  [5];  [5];  [6];  [7];  [8];  [9]; ORCiD logo [10];  [11]; ORCiD logo [8];  [5]; ORCiD logo [5];  [5];  [12];  [13];  [14];  [14] more »;  [14];  [14];  [15];  [12];  [12];  [16];  [17];  [18];  [19];  [20];  [19];  [19];  [19];  [19];  [21];  [22];  [14];  [23]; ORCiD logo [3]; ORCiD logo [24]; ORCiD logo [5];  [12];  [25];  [26]; ORCiD logo [27];  [28]; ORCiD logo [29];  [8] « less
  1. Harvard Medical School, Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  2. Deciphera Pharmaceuticals, Waltham, MA (United States); Harvard Medical School, Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  3. Harvard Medical School, Boston, MA (United States)
  4. Nagoya Univ. Graduate School of Medicine (Japan); Harvard Medical School, Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  5. Dana-Farber Cancer Inst., Boston, MA (United States)
  6. ImmunoGen, Inc., Waltham, MA (United States); Harvard Medical School, Boston, MA (United States)
  7. EMEA Site Intelligence and Activation, Tel Aviv (Israel); Dana-Farber Cancer Inst., Boston, MA (United States)
  8. Harvard Medical School, Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  9. WuXi NextCODE, Cambridge, MA (United States); Harvard Medical School, Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  10. Second Military Medical Univ., Shanghai (China); Yale Univ., New Haven, CT (United States)
  11. Univ. of New Mexico School of Medicine, Albuquerque, NM (United States); Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  12. Johns Hopkins Univ., Baltimore, MD (United States). School of Medicine
  13. Metamark Genetics, Inc., Worcester, MA (United States); Harvard Medical School, Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  14. Baylor-Charles A. Sammons Cancer Center, Dallas, TX (United States)
  15. Univ. of California San Francisco Helen Diller Family Comprehensive Cancer Center, CA (United States)
  16. Johns Hopkins Medical Institutions, Baltimore, MD (United States); Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States)
  17. Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States)
  18. Washington Univ. School of Medicine, St. Louis, MO (United States)
  19. Sutter Roseville Medical Center, Roseville, CA (United States)
  20. Cancer Treatment Centers of America, Atlanta, GA (United States); Sutter Roseville Medical Center, Roseville, CA (United States)
  21. Univ. of Michigan, Ann Arbor, MI (United States)
  22. Duke Univ., Durham, NC (United States); Univ. of California San Francisco Helen Diller Family Comprehensive Cancer Center, CA (United States)
  23. Harvard Univ., Cambridge, MA (United States); Harvard T. H. Chan School of Public Health, Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  24. Yale Univ., New Haven, CT (United States)
  25. Seoul National Univ. College of Medicine (Korea, Republic of)
  26. Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States)
  27. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  28. MD Anderson Cancer Center, Houston, TX (United States)
  29. Harvard Stem Cell Inst., Cambridge, MA (United States); Dana-Farber Cancer Inst., Boston, MA (United States); Brigham and Women's Hospital (Harvard Medical School), Boston, MA (United States)
Publication Date:
Research Org.:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1572055
Grant/Contract Number:  
AC02-05CH11231
Resource Type:
Accepted Manuscript
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 10; Journal Issue: 1; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Ding, Lina, Su, Ying, Fassl, Anne, Hinohara, Kunihiko, Qiu, Xintao, Harper, Nicholas W., Huh, Sung Jin, Bloushtain-Qimron, Noga, Jovanović, Bojana, Ekram, Muhammad, Zi, Xiaoyuan, Hines, William C., Alečković, Maša, Caulfield, Ryan J., Bonal, Dennis M., Nguyen, Quang-De, Merino, Vanessa F., Choudhury, Sibgat, Ethington, Gabrielle, Panos, Laura, Grant, Michael, Herlihy, William, Au, Alfred, Rosson, Gedge D., Argani, Pedram, Richardson, Andrea L., Dillon, Deborah, Allred, D. Craig, Babski, Kirsten, Kim, Elizabeth Min Hui, McDonnell, Charles H., Wagner, Jon, Rowberry, Ron, Bobolis, Kristie, Kleer, Celina G., Hwang, E. Shelley, Blum, Joanne L., Cristea, Simona, Sicinski, Piotr, Fan, Rong, Long, Henry W., Sukumar, Saraswati, Park, So Yeon, Garber, Judy E., Bissell, Mina, Yao, Jun, Polyak, Kornelia, and del Alcazar, Carlos Gil. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. United States: N. p., 2019. Web. doi:10.1038/s41467-019-12125-5.
Ding, Lina, Su, Ying, Fassl, Anne, Hinohara, Kunihiko, Qiu, Xintao, Harper, Nicholas W., Huh, Sung Jin, Bloushtain-Qimron, Noga, Jovanović, Bojana, Ekram, Muhammad, Zi, Xiaoyuan, Hines, William C., Alečković, Maša, Caulfield, Ryan J., Bonal, Dennis M., Nguyen, Quang-De, Merino, Vanessa F., Choudhury, Sibgat, Ethington, Gabrielle, Panos, Laura, Grant, Michael, Herlihy, William, Au, Alfred, Rosson, Gedge D., Argani, Pedram, Richardson, Andrea L., Dillon, Deborah, Allred, D. Craig, Babski, Kirsten, Kim, Elizabeth Min Hui, McDonnell, Charles H., Wagner, Jon, Rowberry, Ron, Bobolis, Kristie, Kleer, Celina G., Hwang, E. Shelley, Blum, Joanne L., Cristea, Simona, Sicinski, Piotr, Fan, Rong, Long, Henry W., Sukumar, Saraswati, Park, So Yeon, Garber, Judy E., Bissell, Mina, Yao, Jun, Polyak, Kornelia, & del Alcazar, Carlos Gil. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. United States. doi:10.1038/s41467-019-12125-5.
Ding, Lina, Su, Ying, Fassl, Anne, Hinohara, Kunihiko, Qiu, Xintao, Harper, Nicholas W., Huh, Sung Jin, Bloushtain-Qimron, Noga, Jovanović, Bojana, Ekram, Muhammad, Zi, Xiaoyuan, Hines, William C., Alečković, Maša, Caulfield, Ryan J., Bonal, Dennis M., Nguyen, Quang-De, Merino, Vanessa F., Choudhury, Sibgat, Ethington, Gabrielle, Panos, Laura, Grant, Michael, Herlihy, William, Au, Alfred, Rosson, Gedge D., Argani, Pedram, Richardson, Andrea L., Dillon, Deborah, Allred, D. Craig, Babski, Kirsten, Kim, Elizabeth Min Hui, McDonnell, Charles H., Wagner, Jon, Rowberry, Ron, Bobolis, Kristie, Kleer, Celina G., Hwang, E. Shelley, Blum, Joanne L., Cristea, Simona, Sicinski, Piotr, Fan, Rong, Long, Henry W., Sukumar, Saraswati, Park, So Yeon, Garber, Judy E., Bissell, Mina, Yao, Jun, Polyak, Kornelia, and del Alcazar, Carlos Gil. Fri . "Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ". United States. doi:10.1038/s41467-019-12125-5. https://www.osti.gov/servlets/purl/1572055.
@article{osti_1572055,
title = {Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ},
author = {Ding, Lina and Su, Ying and Fassl, Anne and Hinohara, Kunihiko and Qiu, Xintao and Harper, Nicholas W. and Huh, Sung Jin and Bloushtain-Qimron, Noga and Jovanović, Bojana and Ekram, Muhammad and Zi, Xiaoyuan and Hines, William C. and Alečković, Maša and Caulfield, Ryan J. and Bonal, Dennis M. and Nguyen, Quang-De and Merino, Vanessa F. and Choudhury, Sibgat and Ethington, Gabrielle and Panos, Laura and Grant, Michael and Herlihy, William and Au, Alfred and Rosson, Gedge D. and Argani, Pedram and Richardson, Andrea L. and Dillon, Deborah and Allred, D. Craig and Babski, Kirsten and Kim, Elizabeth Min Hui and McDonnell, Charles H. and Wagner, Jon and Rowberry, Ron and Bobolis, Kristie and Kleer, Celina G. and Hwang, E. Shelley and Blum, Joanne L. and Cristea, Simona and Sicinski, Piotr and Fan, Rong and Long, Henry W. and Sukumar, Saraswati and Park, So Yeon and Garber, Judy E. and Bissell, Mina and Yao, Jun and Polyak, Kornelia and del Alcazar, Carlos Gil},
abstractNote = {Myoepithelial cells play key roles in normal mammary gland development and in limiting pre-invasive to invasive breast tumor progression, yet their differentiation and perturbation in ductal carcinoma in situ (DCIS) are poorly understood. Here, we investigated myoepithelial cells in normal breast tissues of BRCA1 and BRCA2 germline mutation carriers and in non-carrier controls, and in sporadic DCIS. We found that in the normal breast of non-carriers, myoepithelial cells frequently co-express the p63 and TCF7 transcription factors and that p63 and TCF7 show overlapping chromatin peaks associated with differentiated myoepithelium-specific genes. In contrast, in normal breast tissues of BRCA1 mutation carriers the frequency of p63+TCF7+ myoepithelial cells is significantly decreased and p63 and TCF7 chromatin peaks do not overlap. These myoepithelial perturbations in normal breast tissues of BRCA1 germline mutation carriers may play a role in their higher risk of breast cancer. The fraction of p63+TCF7+ myoepithelial cells is also significantly decreased in DCIS, which may be associated with invasive progression.},
doi = {10.1038/s41467-019-12125-5},
journal = {Nature Communications},
number = 1,
volume = 10,
place = {United States},
year = {2019},
month = {9}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 4 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium
journal, September 2002


Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1
journal, January 2014


Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells
journal, August 2004

  • Dontu, Gabriela; Jackson, Kyle W.; McNicholas, Erin
  • Breast Cancer Research, Vol. 6, Issue 6
  • DOI: 10.1186/bcr920

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
journal, May 2003


Regulation of In Situ to Invasive Breast Carcinoma Transition
journal, May 2008


Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue
journal, August 2011

  • Pasic, L.; Eisinger-Mathason, T. S. K.; Velayudhan, B. T.
  • Genes & Development, Vol. 25, Issue 15
  • DOI: 10.1101/gad.2025611

Numb and Numbl act to determine mammary myoepithelial cell fate, maintain epithelial identity, and support lactogenesis
journal, October 2016


ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling
journal, September 2014

  • Chakrabarti, Rumela; Wei, Yong; Hwang, Julie
  • Nature Cell Biology, Vol. 16, Issue 10
  • DOI: 10.1038/ncb3040

The mammary myoepithelial cell - Cinderella or ugly sister?
journal, February 2000

  • Lakhani, Sunil R.; O'Hare, Michael J.
  • Breast Cancer Research, Vol. 3, Issue 1
  • DOI: 10.1186/bcr260

The importance of being a myoepithelial cell
journal, December 2002

  • Deugnier, Marie-Ange; Teulière, Jérôme; Faraldo, Marisa M.
  • Breast Cancer Research, Vol. 4, Issue 6
  • DOI: 10.1186/bcr459

The myoepithelial defense: a host defense against cancer
journal, January 1997


Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast
journal, March 1999


Phenotypic Alterations in Ductal Carcinoma In Situ-associated Myoepithelial Cells: Biologic and Diagnostic Implications
journal, January 2009

  • Hilson, Justin B.; Schnitt, Stuart J.; Collins, Laura C.
  • The American Journal of Surgical Pathology, Vol. 33, Issue 2
  • DOI: 10.1097/PAS.0b013e318180431d

Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ Progression
journal, November 2015

  • Russell, Tanya D.; Jindal, Sonali; Agunbiade, Samiat
  • The American Journal of Pathology, Vol. 185, Issue 11
  • DOI: 10.1016/j.ajpath.2015.07.004

CD10-positive myoepithelial cells are usually prominent around in situ lobular neoplasia of the breast and much less prominent or absent in DCIS
journal, February 2016


Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
journal, December 2011

  • Knudsen, Erik S.; Ertel, Adam; Davicioni, Elai
  • Breast Cancer Research and Treatment, Vol. 133, Issue 3
  • DOI: 10.1007/s10549-011-1894-3

Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)
journal, August 2010


Morphologic, molecular and microenvironment factors associated with stromal invasion in breast ductal carcinoma in situ: Role of myoepithelial cells
journal, November 2015

  • Aguiar, Fernando N.; Cirqueira, Cinthya S.; Bacchi, Carlos E.
  • Breast Disease, Vol. 35, Issue 4
  • DOI: 10.3233/BD-150416

Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland.
journal, August 1993


The CD10 Enzyme Is a Key Player to Identify and Regulate Human Mammary Stem Cells
journal, April 2010

  • Bachelard-Cascales, Elodie; Chapellier, Marion; Delay, Emmanuel
  • STEM CELLS, Vol. 28, Issue 6
  • DOI: 10.1002/stem.435

Self-organization is a dynamic and lineage-intrinsic property of mammary epithelial cells
journal, February 2011

  • Chanson, L.; Brownfield, D.; Garbe, J. C.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 8
  • DOI: 10.1073/pnas.1019556108

Molecular characterization of the tumor microenvironment in breast cancer
journal, July 2004


Distinct epigenetic changes in the stromal cells of breast cancers
journal, July 2005

  • Hu, Min; Yao, Jun; Cai, Li
  • Nature Genetics, Vol. 37, Issue 8
  • DOI: 10.1038/ng1596

Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast
journal, February 2009

  • Hu, M.; Peluffo, G.; Chen, H.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 9
  • DOI: 10.1073/pnas.0813306106

Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
journal, June 2017


MCF10DCIS.com Xenograft Model of Human Comedo Ductal Carcinoma In Situ
journal, July 2000

  • Miller, Fred R.; Santner, Steven J.; Tait, Larry
  • JNCI: Journal of the National Cancer Institute, Vol. 92, Issue 14
  • DOI: 10.1093/jnci/92.14.1185a

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
journal, August 2009

  • Lim, Elgene; Vaillant, François; Wu, Di
  • Nature Medicine, Vol. 15, Issue 8
  • DOI: 10.1038/nm.2000

Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
journal, February 2011


BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells
journal, July 2016


Transcriptome Analysis of the Normal Human Mammary Cell Commitment and Differentiation Process
journal, July 2008


A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability
journal, November 2008

  • Eirew, Peter; Stingl, John; Raouf, Afshin
  • Nature Medicine, Vol. 14, Issue 12
  • DOI: 10.1038/nm.1791

Cell type-specific DNA methylation patterns in the human breast
journal, September 2008

  • Bloushtain-Qimron, N.; Yao, J.; Snyder, E. L.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 37
  • DOI: 10.1073/pnas.0805206105

Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27+ Cell Population with Progenitor Characteristics
journal, July 2013


ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
journal, November 2007

  • Ginestier, Christophe; Hur, Min Hee; Charafe-Jauffret, Emmanuelle
  • Cell Stem Cell, Vol. 1, Issue 5
  • DOI: 10.1016/j.stem.2007.08.014

p63 is a p53 homologue required for limb and epidermal morphogenesis
journal, April 1999

  • Mills, Alea A.; Zheng, Binhai; Wang, Xiao-Jing
  • Nature, Vol. 398, Issue 6729
  • DOI: 10.1038/19531

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
journal, April 1999

  • Yang, Annie; Schweitzer, Ronen; Sun, Deqin
  • Nature, Vol. 398, Issue 6729
  • DOI: 10.1038/19539

Synergy Between Tumor Suppressor APC and the -Catenin-Tcf4 Target Tcf1
journal, September 1999


p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress
journal, April 2006

  • Murray-Zmijewski, F.; Lane, D. P.; Bourdon, J-C
  • Cell Death & Differentiation, Vol. 13, Issue 6
  • DOI: 10.1038/sj.cdd.4401914

Diversity of LEF/TCF action in development and disease
journal, December 2006


Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast
journal, July 2008


p63 in Epithelial Survival, Germ Cell Surveillance, and Neoplasia
journal, January 2010


Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
journal, April 2013


Models of human core transcriptional regulatory circuitries
journal, February 2016

  • Saint-André, Violaine; Federation, Alexander J.; Lin, Charles Y.
  • Genome Research, Vol. 26, Issue 3
  • DOI: 10.1101/gr.197590.115

STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene
journal, September 2000


Target analysis by integration of transcriptome and ChIP-seq data with BETA
journal, November 2013


p63-Associated Disorders
journal, February 2007

  • Rinne, Tuula; Brunner, Hans G.; van Bokhoven, Hans
  • Cell Cycle, Vol. 6, Issue 3
  • DOI: 10.4161/cc.6.3.3796

Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)
journal, October 2006

  • Ingraham, Christopher R.; Kinoshita, Akira; Kondo, Shinji
  • Nature Genetics, Vol. 38, Issue 11
  • DOI: 10.1038/ng1903

Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control
journal, December 2000


Wnt signalling: variety at the core
journal, January 2007

  • Hoppler, S.; Kavanagh, C. L.
  • Journal of Cell Science, Vol. 120, Issue 3
  • DOI: 10.1242/jcs.03363

Genetics of Colonic Cancer
journal, January 1998


Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency
journal, September 2002

  • Gallagher, Ronald C. J.; Hay, Trevor; Meniel, Valerie
  • Oncogene, Vol. 21, Issue 42
  • DOI: 10.1038/sj.onc.1205892

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
journal, January 2018


Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer
journal, July 2012


Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression
journal, April 2006


KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
journal, December 2018


ChiLin: a comprehensive ChIP-seq and DNase-seq quality control and analysis pipeline
journal, October 2016


Fast and accurate short read alignment with Burrows-Wheeler transform
journal, May 2009


Model-based Analysis of ChIP-Seq (MACS)
journal, January 2008


deepTools2: a next generation web server for deep-sequencing data analysis
journal, April 2016

  • Ramírez, Fidel; Ryan, Devon P.; Grüning, Björn
  • Nucleic Acids Research, Vol. 44, Issue W1
  • DOI: 10.1093/nar/gkw257

STAR: ultrafast universal RNA-seq aligner
journal, October 2012


Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
journal, December 2014


Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
journal, May 2011


UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity
journal, September 2012

  • Wang, C.; Lee, J. -E.; Cho, Y. -W.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 38
  • DOI: 10.1073/pnas.1204166109

    Works referencing / citing this record:

    Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell composition
    journal, March 2020

    • Mitchell, Elizabeth; Jindal, Sonali; Chan, Tiffany
    • Molecular Carcinogenesis, Vol. 59, Issue 7
    • DOI: 10.1002/mc.23171